A new deal between GNS Healthcare Inc. and Covance Inc. to develop predictive clinical trial models for diabetes is one example of how big data tools are being applied to drug development. Last week, GNS...
Data analytics company GNS Healthcare partnered with the not-for-profit foundation to create a computer model of Huntington's disease (HD). GNS is providing its Reverse Engineering and Forward Simulation (REFS) modeling technology, while CHDI is providing...
Data analytics company GNS Healthcare Inc. (Cambridge, Mass.) partnered with the not-for-profit CHDI Foundation Inc. to create a computer model of Huntington's disease. GNS is providing its Reverse Engineering and Forward Simulation (REFS) modeling technology,...
The most widely used animal model of HCV infection requires transplanting human hepatocytes into immunodeficient mice. These mice are useful for testing antivirals, but the absence of an immune system makes the animals unsuitable for...
The biotech partnered with researchers from the university, institute, BGI's Beijing Genomics Institute Europe A/S subsidiary and Genomic Expression to identify and develop vaccines against cancer-causing pathogens, with a focus on breast, prostate and colon...
Fisher Scientific Inc., part of Thermo Fisher, will distribute the GeneAtlas personal microarray system for whole-genome expression in the U.S. and Canada. Last year, Affymetrix launched the system for use in low- to medium-throughput service...
NuView received an exclusive license to the university's molecular imaging compound to identify genomic expressions linked to prostate cancer. The gene guided radioactive probe targets elevated levels of the vasoactive intestinal peptide receptor 1 (VPAC1)...
The I-SPY 2 trial, launched last week, is intended to both speed development of compounds for locally advanced breast cancer and to serve as a model for integrating biomarkers, adaptive trial designs, and bioinformatics to...
A new deal between GNS Healthcare Inc. and Covance Inc. to develop predictive clinical trial models for diabetes is one example of how big data tools are being applied to drug development. Last week, GNS...
Data analytics company GNS Healthcare partnered with the not-for-profit foundation to create a computer model of Huntington's disease (HD). GNS is providing its Reverse Engineering and Forward Simulation (REFS) modeling technology, while CHDI is providing...
Data analytics company GNS Healthcare Inc. (Cambridge, Mass.) partnered with the not-for-profit CHDI Foundation Inc. to create a computer model of Huntington's disease. GNS is providing its Reverse Engineering and Forward Simulation (REFS) modeling technology,...
The most widely used animal model of HCV infection requires transplanting human hepatocytes into immunodeficient mice. These mice are useful for testing antivirals, but the absence of an immune system makes the animals unsuitable for...
The biotech partnered with researchers from the university, institute, BGI's Beijing Genomics Institute Europe A/S subsidiary and Genomic Expression to identify and develop vaccines against cancer-causing pathogens, with a focus on breast, prostate and colon...
Fisher Scientific Inc., part of Thermo Fisher, will distribute the GeneAtlas personal microarray system for whole-genome expression in the U.S. and Canada. Last year, Affymetrix launched the system for use in low- to medium-throughput service...
NuView received an exclusive license to the university's molecular imaging compound to identify genomic expressions linked to prostate cancer. The gene guided radioactive probe targets elevated levels of the vasoactive intestinal peptide receptor 1 (VPAC1)...
The I-SPY 2 trial, launched last week, is intended to both speed development of compounds for locally advanced breast cancer and to serve as a model for integrating biomarkers, adaptive trial designs, and bioinformatics to...
